Assessing the Role of APNH, a Gene Encoding for a Human Amiloride

Total Page:16

File Type:pdf, Size:1020Kb

Assessing the Role of APNH, a Gene Encoding for a Human Amiloride Assessing the Role of APNH, a Gene Encoding for a Human Amiloride-Sensitive Na/H Antiporter, on the Interindividual Variation in Red Cell Na/Li Count ert ransport1 Christopher R.K. Dudley,2 Luis A. Giuffra, Anthony E.G. Rome, and Stephen T. Reeders correction of SIC values for known covariotes. There C.R.K. Dudley, S.T. Reeders, Department of Internal was no significant association between mean SIC Medicine. Yale University School of Medicine, New- values and any of the three possible genotypes of Haven, CT the APNH locus either before or after regressing out L.A. Giuffra, ST. Reeders, Department of Human Ge- covariates (F= 0.64 and P> 0.52; F= 0.63 and P> netics, Yale University School of Medicine, New- 0.53, respectively). Linkage analysis similarly foiled Haven, CT to demonstrate a relationship between the squared A.E.G. Rome, Department of Nephrology, The Royal difference In SIC values and the identity by descent Hospital of St. Bartholomew, London, England status for APNH as well as other loci that map close to APNH (D1S57, RH, and ALPI). Taking these results (J. Am. Soc. Nephrol. 1991; 2:937-943) together, we conclude that mutations at the APNH locus are not responsible for the observed variation in SIC values. ABSTRACT Key Words: Blood pressure, intermediate phenotype, associ- The “reverse genetic” approach to essential hyper- ation study, sib pair method, linkage analysis tension Is complicated by the tact that blood pres- sure is a heterogeneous, quantitative, complex trait. One strategy is to use Intermediate phenotypes” that are not only associated with hypertension but S ince the original observation by Canessa et at. that also have a simple mode of inheritance, com- demonstrating an association between red cell patible with the action of a single gene. Red cell sodium-lIthium countertransport (SLC) and essential sodium-lithium countertransport (SIC) is one of the hypertension (1), a number of other groups have best characterized intermediate phenotypes for hy- reported similar findings (2.3). Genetic studies of pertension. The similarity in stoichiometry and kinet- countertransport levels have shown familial aggre- ics between SIC and Na/H exchange has led to gation and a higher concordance rate for monozygotic than for dizygotic twins (4.5). These findings suggest the proposal that the gene encoding the Na/H that SLC has a major heritable component and estI- antiporter (APNH) may be responsible for the individ- mates that up to 80 to 90% of the individual variance ual variance in SIC. We have tested this hypothesis in SLC is accounted for by inherited factors (5.6). by both an association study and Haseman and Complex segregation analysis has been performed to Elston’s sib pair method of linkage analysis, by using determine which of a variety of genetic models best a polymorphism at the APNH locus detected by de- explains the familial pattern of SLC values, Two such naturing gradient gel electrophoresis. Both analyti- studies provide evidence for the action of a single cal techniques were performed before and after major gene on a polygenic background (7,8). These results have important implications, not the least of which is that the same genes that determine SLC values may also be involved in the pathogenesis of ‘ReceIved December 18, 1990. Accepted June I, 1991. 2Correspondence to Df. C.RK. Dudley. Nuffteld Department of Clinical Medi- hypertension. The identification of such genes, cine, John Radcliffe Hospital, Headinglon, Oxford 0X3 9DU. England. therefore. may provide important insights into the l0466673/0204-0937$03.O0/0 mechanisms determining blood pressure variation Journal of the Ameflcan Society of Nephrology Copyright 0 1991 by the American Society of Nephroiogy and control. Journal of the American Society of Nephromogy 937 APNH and Na/Li Countertransporf The physIological role of the transport system that 7.4) at 4#{176}C.SLC activity was determined by measur- mediates In vitro erythrocyte SLC is not established. ing, in parallel and in duplicate, lithium efflux from The similarity In kinetics and stoichiometry between loaded cells into a sodium-contaIning medium (150 SLC and Na/H countertransport has led to the pro- mM NaC1, 10 mM glucose, 0.1 mM ouabain, and 10 posal that red cell SLC is carried out by the ubiqui- mM Tris-MOPS [pH 7.4J at 37#{176}C)and into a sodium- tously distributed Na/H antiporter (9,10). In sup- free medium (110 mM magnesium chloride, 10 mM port of this argument is the demonstration that both glucose, 0.1 mM ouabain, and 10 mM Tris-MOPS [pH SLC and Na/H exchange in sarcolemmal vesicles 7.4] at 37#{176}C)incubated at 37#{176}C.After 0, 20, 40 and from bovine artery are mediated by a single ethyli- 60 mm of incubation, duplicate samples were taken sopropyl amiloride-sensitive cation exchanger with from duplicate tubes, cooled quickly to 4#{176}C,and cen- affinity for sodium, lithium, and hydrogen ions (11). trifuged. Furthermore, Na/H antiport activity has been re- The lithium concentration in the supernatant was ported to be elevated in leukocytes and platelets from determined by atomic-absorption spectrophotome- patients with hypertension (12.13) as well as in ge- try. The hematocrit of each efflux medium was meas- netically hypertensive rats (14,15). ured at the end of the experiment by using a Coulter A flbroblast Na7H antiporter cDNA has been counter. The lithium efflux rates in the sodium-free cloned by complementation (16) and mapped by in and sodium-containing media were taken as the situ hybridization to chromosome lp (17). Linkage slopes of the linear regression lines calculated with studies have placed the genomic locus for this Na/ lithium efflux as a function of time. Correlation coef- H antiporter (designated APNH) close to the rhesus ficients greater than 0.98 were considered accepta- locus (RH) (18,19). It has been proposed that the ble. Net SLC activity was calculated by subtracting APNH gene product carries out SLC and is responsi- the lithium efflux rate in the sodium-free medium ble for the variation observed in SLC values (20,21). from that In the sodium-containing medium and was We have tested this hypothesis by association studies expressed as millimoles of lithium released from one and by the sib pair method of linkage analysis by liter of red cells per hour. The coefficient of variation using members from six large pedigrees in whom of repeated assays was 10%. SLC was measured. Because the power of the sib pair method is limited by a requirement for a highly in- APNH Polymorphism formative locus, we have also performed linkage analysis between SLC and other polymorphic loci A polymorphism in the APNH gene was detected by (namely D1S57, RH, and ALPL, the gene for alkaline denaturing gradient gel electrophoresis (DGGE). A phosphatase), which map close to APNH. 376-base-pair product of the polymerase chain re- action (PCR). corresponding to nucleotides -25 .e METHODS +351 of the coding sequence for APNH, (where + 1 is the first nucleotide of the translation initiation co- Subjects don) (16), was generated by using genomic DNA from As part of a broader study on the genetic determi- each individual as a template. This product was then nants of blood pressure, 190 individuals from six subjected to DOGE on a 35 to 65% gradient as de- large English kindreds were evaluated. Subjects were scribed previously (18). seen by a single investigator, weight was measured DGCIE is a powerful technique allowing two DNA in a standardized way, and blood was drawn for DNA fragments differing by as little as a single base sub- analysis and assay of SLC activity. Thirty-six sub- stitution to be physically separated from each other jects were receiving one or more antihypertensive (23). The method can be further enhanced by allow- agents at the time of the investigation. ing denatured PCR products to reanneal. creating heteroduplex DNA in regions where sequence poly- SIC Activity morphism exists as shown (Figure 1). PCR products SLC was measured as the rate of sodium-dependent from individuals homozygous for each allele were lithium efflux from lithium loaded red blood cells as subcloned into pBSII (Stratagene) and sequenced. Se- described by Canessa et at. (1) and as modified by quence comparison revealed that a single base-pair Smith et at. (22). In brief, washed red cells were substitution of cytosine for thymine at nucleotide 69 suspended at a hematocrit of approximately 20% In distinguishes two alleles, designated Cl and C2 (Fig- a loading solution consisting of 150 mM lithium chlo- ure 2). Although this substitution does not alter the ride, 10 mM glucose, and 10 mM Tris-morpholine- amino acid sequence, It is responsible for the poly- propanesulfonic acid (MOPS) (pH 7.4) and were In- morphism detected by DOGE. The cytosine at posi- cubated in a shaking water bath at 37#{176}Cfor 3 h. tIon 69 in the C2 allele confers greater stability on After loading, external lithium was removed by five the DNA duplex under denaturing conditions and washings with 75 mM magnesium chloride, 85 mM allows the DNA fragment to migrate further down sucrose, 10 mM glucose, and 10 mM Tris-MOPS (pH the denaturing gradient before “melting” occurs. 938 Volume 2 ‘ Number 4 #{149}1991 Dudley et al Statistical Methods The possible genetic role of APNH in SLC variation was tested in two ways. Association Studies. Mean values for SLC were compared by analysis of variance (ANOVA) across the three genotypes (C1C1, C1C2, and C2C2) that 23 4 56 7 could be detected at the APNH locus by using the DGGE polymorphism described above.
Recommended publications
  • Epithelial Delamination Is Protective During Pharmaceutical-Induced Enteropathy
    Epithelial delamination is protective during pharmaceutical-induced enteropathy Scott T. Espenschieda, Mark R. Cronana, Molly A. Mattya, Olaf Muellera, Matthew R. Redinbob,c,d, David M. Tobina,e,f, and John F. Rawlsa,e,1 aDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710; bDepartment of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; cDepartment of Biochemistry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599; dDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599; eDepartment of Medicine, Duke University School of Medicine, Durham, NC 27710; and fDepartment of Immunology, Duke University School of Medicine, Durham, NC 27710 Edited by Dennis L. Kasper, Harvard Medical School, Boston, MA, and approved July 15, 2019 (received for review February 12, 2019) Intestinal epithelial cell (IEC) shedding is a fundamental response to in mediating intestinal responses to injury remains poorly un- intestinal damage, yet underlying mechanisms and functions have derstood for most xenobiotics. been difficult to define. Here we model chronic intestinal damage in Gastrointestinal pathology is common in people using phar- zebrafish larvae using the nonsteroidal antiinflammatory drug maceuticals, including nonsteroidal antiinflammatory drugs (NSAID) Glafenine. Glafenine induced the unfolded protein response (NSAIDs) (11). While gastric ulceration has historically been a (UPR) and inflammatory pathways in IECs, leading to delamination. defining clinical presentation of NSAID-induced enteropathy, Glafenine-induced inflammation was augmented by microbial colo- small intestinal pathology has also been observed, although the nizationandassociatedwithchanges in intestinal and environmental incidence may be underreported due to diagnostic limitations microbiotas.
    [Show full text]
  • Global Analysis of Protein Folding Thermodynamics for Disease State Characterization
    Global Analysis of Protein Folding Thermodynamics for Disease State Characterization and Biomarker Discovery by Jagat Adhikari Department of Biochemistry Duke University Date:_______________________ Approved: ___________________________ Michael C. Fitzgerald, Supervisor ___________________________ Kenneth Kreuzer ___________________________ Terrence G. Oas ___________________________ Jiyong Hong ___________________________ Seok-Yong Lee Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biochemistry in the Graduate School of Duke University 2015 ABSTRACT Global Analysis of Protein Folding Thermodynamics for Disease State Characterization and Biomarker Discovery by Jagat Adhikari Department of Biochemistry Duke University Date:_______________________ Approved: ___________________________ Michael C. Fitzgerald, Supervisor ___________________________ Kenneth Kreuzer ___________________________ Terrence G. Oas ___________________________ Jiyong Hong ___________________________ Seok-Yong Lee An abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biochemistry in the Graduate School of Duke University 2015 Copyright by Jagat Adhikari 2015 Abstract Protein biomarkers can facilitate the diagnosis of many diseases such as cancer and they can be important for the development of effective therapeutic interventions. Current large-scale biomarker discovery and disease state characterization
    [Show full text]
  • Supplementary Table S1. Prioritization of Candidate FPC Susceptibility Genes by Private Heterozygous Ptvs
    Supplementary Table S1. Prioritization of candidate FPC susceptibility genes by private heterozygous PTVs Number of private Number of private Number FPC patient heterozygous PTVs in heterozygous PTVs in tumors with somatic FPC susceptibility Hereditary cancer Hereditary Gene FPC kindred BCCS samples mutation DNA repair gene Cancer driver gene gene gene pancreatitis gene ATM 19 1 - Yes Yes Yes Yes - SSPO 12 8 1 - - - - - DNAH14 10 3 - - - - - - CD36 9 3 - - - - - - TET2 9 1 - - Yes - - - MUC16 8 14 - - - - - - DNHD1 7 4 1 - - - - - DNMT3A 7 1 - - Yes - - - PKHD1L1 7 9 - - - - - - DNAH3 6 5 - - - - - - MYH7B 6 1 - - - - - - PKD1L2 6 6 - - - - - - POLN 6 2 - Yes - - - - POLQ 6 7 - Yes - - - - RP1L1 6 6 - - - - - - TTN 6 5 4 - - - - - WDR87 6 7 - - - - - - ABCA13 5 3 1 - - - - - ASXL1 5 1 - - Yes - - - BBS10 5 0 - - - - - - BRCA2 5 6 1 Yes Yes Yes Yes - CENPJ 5 1 - - - - - - CEP290 5 5 - - - - - - CYP3A5 5 2 - - - - - - DNAH12 5 6 - - - - - - DNAH6 5 1 1 - - - - - EPPK1 5 4 - - - - - - ESYT3 5 1 - - - - - - FRAS1 5 4 - - - - - - HGC6.3 5 0 - - - - - - IGFN1 5 5 - - - - - - KCP 5 4 - - - - - - LRRC43 5 0 - - - - - - MCTP2 5 1 - - - - - - MPO 5 1 - - - - - - MUC4 5 5 - - - - - - OBSCN 5 8 2 - - - - - PALB2 5 0 - Yes - Yes Yes - SLCO1B3 5 2 - - - - - - SYT15 5 3 - - - - - - XIRP2 5 3 1 - - - - - ZNF266 5 2 - - - - - - ZNF530 5 1 - - - - - - ACACB 4 1 1 - - - - - ALS2CL 4 2 - - - - - - AMER3 4 0 2 - - - - - ANKRD35 4 4 - - - - - - ATP10B 4 1 - - - - - - ATP8B3 4 6 - - - - - - C10orf95 4 0 - - - - - - C2orf88 4 0 - - - - - - C5orf42 4 2 - - - -
    [Show full text]
  • Supplemental Materials Supplemental Table 1
    Electronic Supplementary Material (ESI) for RSC Advances. This journal is © The Royal Society of Chemistry 2016 Supplemental Materials Supplemental Table 1. The differentially expressed proteins from rat pancreas identified by proteomics (SAP vs. SO) No. Protein name Gene name ratio P value 1 Metallothionein Mt1m 3.35 6.34E-07 2 Neutrophil antibiotic peptide NP-2 Defa 3.3 8.39E-07 3 Ilf2 protein Ilf2 3.18 1.75E-06 4 Numb isoform o/o rCG 3.12 2.73E-06 5 Lysozyme Lyz2 3.01 5.63E-06 6 Glucagon Gcg 2.89 1.17E-05 7 Serine protease HTRA1 Htra1 2.75 2.97E-05 8 Alpha 2 macroglobulin cardiac isoform (Fragment) 2.75 2.97E-05 9 Myosin IF (Predicted) Myo1f 2.65 5.53E-05 10 Neuroendocrine secretory protein 55 Gnas 2.61 7.60E-05 11 Matrix metallopeptidase 8 Mmp8 2.57 9.47E-05 12 Protein Tnks1bp1 Tnks1bp1 2.53 1.22E-04 13 Alpha-parvin Parva 2.47 1.78E-04 14 C4b-binding protein alpha chain C4bpa 2.42 2.53E-04 15 Protein KTI12 homolog Kti12 2.41 2.74E-04 16 Protein Rab11fip5 Rab11fip5 2.41 2.84E-04 17 Protein Mcpt1l3 Mcpt1l3 2.33 4.43E-04 18 Phospholipase B-like 1 Plbd1 2.33 4.76E-04 Aldehyde dehydrogenase (NAD), cytosolic 19 2.32 4.93E-04 (Fragments) 20 Protein Dpy19l2 Dpy19l2 2.3 5.68E-04 21 Regenerating islet-derived 3 alpha, isoform CRA_a Reg3a 2.27 6.74E-04 22 60S acidic ribosomal protein P1 Rplp1 2.26 7.22E-04 23 Serum albumin Alb 2.25 7.98E-04 24 Ribonuclease 4 Rnase4 2.24 8.25E-04 25 Cct-5 protein (Fragment) Cct5 2.24 8.52E-04 26 Protein S100-A9 S100a9 2.22 9.71E-04 27 Creatine kinase M-type Ckm 2.21 1.00E-03 28 Protein Larp4b Larp4b 2.18 1.25E-03
    [Show full text]
  • MALE Protein Name Accession Number Molecular Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean H Mean PDAC Mean T-Test PDAC Vs. H T-Test
    MALE t-test t-test Accession Molecular H PDAC PDAC vs. PDAC vs. Protein Name Number Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean Mean Mean H CP PDAC/H PDAC/CP - 22 kDa protein IPI00219910 22 kDa 7 5 4 8 1 0 6 6 1 0.1126 0.0456 0.1 0.1 - Cold agglutinin FS-1 L-chain (Fragment) IPI00827773 12 kDa 32 39 34 26 53 57 36 30 55 0.0309 0.0388 1.8 1.5 - HRV Fab 027-VL (Fragment) IPI00827643 12 kDa 4 6 0 0 0 0 5 0 0 - 0.0574 - 0.0 - REV25-2 (Fragment) IPI00816794 15 kDa 8 12 5 7 8 9 10 6 8 0.2225 0.3844 1.3 0.8 A1BG Alpha-1B-glycoprotein precursor IPI00022895 54 kDa 115 109 106 112 111 100 112 109 105 0.6497 0.4138 1.0 0.9 A2M Alpha-2-macroglobulin precursor IPI00478003 163 kDa 62 63 86 72 14 18 63 79 16 0.0120 0.0019 0.2 0.3 ABCB1 Multidrug resistance protein 1 IPI00027481 141 kDa 41 46 23 26 52 64 43 25 58 0.0355 0.1660 2.4 1.3 ABHD14B Isoform 1 of Abhydrolase domain-containing proteinIPI00063827 14B 22 kDa 19 15 19 17 15 9 17 18 12 0.2502 0.3306 0.7 0.7 ABP1 Isoform 1 of Amiloride-sensitive amine oxidase [copper-containing]IPI00020982 precursor85 kDa 1 5 8 8 0 0 3 8 0 0.0001 0.2445 0.0 0.0 ACAN aggrecan isoform 2 precursor IPI00027377 250 kDa 38 30 17 28 34 24 34 22 29 0.4877 0.5109 1.3 0.8 ACE Isoform Somatic-1 of Angiotensin-converting enzyme, somaticIPI00437751 isoform precursor150 kDa 48 34 67 56 28 38 41 61 33 0.0600 0.4301 0.5 0.8 ACE2 Isoform 1 of Angiotensin-converting enzyme 2 precursorIPI00465187 92 kDa 11 16 20 30 4 5 13 25 5 0.0557 0.0847 0.2 0.4 ACO1 Cytoplasmic aconitate hydratase IPI00008485 98 kDa 2 2 0 0 0 0 2 0 0 - 0.0081 - 0.0
    [Show full text]
  • Journal of Environment and Health Sciences
    Journal of Environment and Health Sciences Review Article Organophosphorus Flame Retardants (OPFR): Neurotoxicity Mohamed B. Abou-Donia1* Mohamed Salama2, Mohamed Elgamal2, Islam Elkholi2,3, Qiangwei Wang1,4 1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA 2Medical Experimental Research Center (MERC), Faculty of Medicine, Mansoura University, Mansoura, Egypt 3Center for Aging and Associated Diseases (CAAD), Zewail City of Science and Technology, Giza 4Zhejiang University, China *Corresponding author: Mohamed B. Abou-Donia, Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 277, USA, Tel: +919-68422/ Fax: 919-681-822, E-mail: [email protected] Citation: Abou-Donia, M.B., et al. Organophosphorus Flame Retardants (OPFR): Neurotoxicity. (2016) J Environ Health Sci 2(1): 1- 30 Received date: July 07, 2015 Accepted date: May 05, 2016 DOI: 10.15436/2378-6841.16.022 Published date: May 11, 2016 Abstract Organophosphorus flame retardants (OPFRs) are used as additives in plasticizers, foams, hydraulic fluids, anti-foam agents, and coatings for electronic components/devices to inhibit flames. These chemicals were developed and used as flame re- tardants because of environmental and health concerns of previously used brominated and chlorinated flame retardants (FRs). OPCFRs are divided into five main groups: organophosphates, organophosphonates, organophosphinates, organoposphine oxide, and organophosphites. Most of OPFRs are organophosphate esters that are further classified into the following five groups: 1. Ali- phatic, 2. Brominated aliphatic, 3. Chlorinated aliphatic, 4. Aromatic-aliphatic, and 5. Aromatic phosphates. These OPFRs have the following neurotoxic actions: 1. Cholinergic Neurotoxicity, 2. Organophosphate-Induced Delayed Neurotoxicity (OPIDN), and 3.
    [Show full text]
  • Downregulation of Carnitine Acyl-Carnitine Translocase by Mirnas
    Page 1 of 288 Diabetes 1 Downregulation of Carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretion Mufaddal S. Soni1, Mary E. Rabaglia1, Sushant Bhatnagar1, Jin Shang2, Olga Ilkayeva3, Randall Mynatt4, Yun-Ping Zhou2, Eric E. Schadt6, Nancy A.Thornberry2, Deborah M. Muoio5, Mark P. Keller1 and Alan D. Attie1 From the 1Department of Biochemistry, University of Wisconsin, Madison, Wisconsin; 2Department of Metabolic Disorders-Diabetes, Merck Research Laboratories, Rahway, New Jersey; 3Sarah W. Stedman Nutrition and Metabolism Center, Duke Institute of Molecular Physiology, 5Departments of Medicine and Pharmacology and Cancer Biology, Durham, North Carolina. 4Pennington Biomedical Research Center, Louisiana State University system, Baton Rouge, Louisiana; 6Institute for Genomics and Multiscale Biology, Mount Sinai School of Medicine, New York, New York. Corresponding author Alan D. Attie, 543A Biochemistry Addition, 433 Babcock Drive, Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, (608) 262-1372 (Ph), (608) 263-9608 (fax), [email protected]. Running Title: Fatty acyl-carnitines enhance insulin secretion Abstract word count: 163 Main text Word count: 3960 Number of tables: 0 Number of figures: 5 Diabetes Publish Ahead of Print, published online June 26, 2014 Diabetes Page 2 of 288 2 ABSTRACT We previously demonstrated that micro-RNAs 132 and 212 are differentially upregulated in response to obesity in two mouse strains that differ in their susceptibility to obesity-induced diabetes. Here we show the overexpression of micro-RNAs 132 and 212 enhances insulin secretion (IS) in response to glucose and other secretagogues including non-fuel stimuli. We determined that carnitine acyl-carnitine translocase (CACT, Slc25a20) is a direct target of these miRNAs.
    [Show full text]
  • Urtica Dioica L.): Spotlight on a Neglected Fibre Crop
    Received: 15 May 2019 | Revised: 18 June 2019 | Accepted: 21 June 2019 DOI: 10.1002/pld3.151 ORIGINAL RESEARCH Cell wall composition and transcriptomics in stem tissues of stinging nettle (Urtica dioica L.): Spotlight on a neglected fibre crop Xuan Xu1 | Aurélie Backes1 | Sylvain Legay1 | Roberto Berni2,3 | Claudia Faleri2 | Edoardo Gatti4 | Jean‐Francois Hausman1 | Giampiero Cai2 | Gea Guerriero1 1Environmental Research and Innovation (ERIN) Department, Luxembourg Institute of Abstract Science and Technology (LIST), Esch/Alzette, Stinging nettle (Urtica dioica L.) produces silky cellulosic fibres, as well as bioactive Luxembourg molecules. To improve the knowledge on nettle and enhance its opportunities of 2Department of Life Sciences, University of Siena, Siena, Italy exploitation, a draft transcriptome of the “clone 13” (a fibre clone) is here presented. 3Trees and Timber Institute-National The transcriptome of whole internodes sampled at the top and middle of the stem is Research Council of Italy (CNR-IVALSA), Follonica, Italy then compared with the core and cortical tissues sampled at the bottom. Young inter- 4Institute of Biometeorology nodes show an enrichment in genes involved in the biosynthesis of phytohormones (IBIMET), National Research Council, (auxins and jasmonic acid) and secondary metabolites (flavonoids). The core of inter- Bologna, Italy nodes collected at the bottom of the stem is enriched in genes partaking in different Correspondence aspects of secondary cell wall formation (cellulose, hemicellulose, lignin biosynthe- Gea Guerriero, Luxembourg Institute of Science and Technology (LIST), sis), while the cortical tissues reveal the presence of a C starvation signal probably Environmental Research and Innovation due to the UDP-glucose demand necessary for the thickening phase of bast fibres.
    [Show full text]
  • Tissue-Nonspecific Alkaline Phosphatase
    biomolecules Review Tissue-Nonspecific Alkaline Phosphatase— A Gatekeeper of Physiological Conditions in Health and a Modulator of Biological Environments in Disease Daniel Liedtke 1,* , Christine Hofmann 2, Franz Jakob 3, Eva Klopocki 1 and Stephanie Graser 3 1 Institute for Human Genetics, Biocenter, Julius-Maximilians-University Würzburg, 97074 Würzburg, Germany; [email protected] 2 Section of Pediatric Rheumatology and Osteology, University Children’s Hospital of Würzburg, 97080 Würzburg, Germany; [email protected] 3 Bernhard-Heine-Center for Locomotion Research, Julius-Maximilians-University Würzburg, 97076 Würzburg, Germany; [email protected] (F.J.); [email protected] (S.G.) * Correspondence: [email protected] Received: 30 October 2020; Accepted: 5 December 2020; Published: 8 December 2020 Abstract: Tissue-nonspecific alkaline phosphatase (TNAP) is a ubiquitously expressed enzyme that is best known for its role during mineralization processes in bones and skeleton. The enzyme metabolizes phosphate compounds like inorganic pyrophosphate and pyridoxal-50-phosphate to provide, among others, inorganic phosphate for the mineralization and transportable vitamin B6 molecules. Patients with inherited loss of function mutations in the ALPL gene and consequently altered TNAP activity are suffering from the rare metabolic disease hypophosphatasia (HPP). This systemic disease is mainly characterized by impaired bone and dental mineralization but may also be accompanied by neurological symptoms, like anxiety disorders, seizures, and depression. HPP characteristically affects all ages and shows a wide range of clinical symptoms and disease severity, which results in the classification into different clinical subtypes. This review describes the molecular function of TNAP during the mineralization of bones and teeth, further discusses the current knowledge on the enzyme’s role in the nervous system and in sensory perception.
    [Show full text]
  • Live-Cell Imaging Rnai Screen Identifies PP2A–B55α and Importin-Β1 As Key Mitotic Exit Regulators in Human Cells
    LETTERS Live-cell imaging RNAi screen identifies PP2A–B55α and importin-β1 as key mitotic exit regulators in human cells Michael H. A. Schmitz1,2,3, Michael Held1,2, Veerle Janssens4, James R. A. Hutchins5, Otto Hudecz6, Elitsa Ivanova4, Jozef Goris4, Laura Trinkle-Mulcahy7, Angus I. Lamond8, Ina Poser9, Anthony A. Hyman9, Karl Mechtler5,6, Jan-Michael Peters5 and Daniel W. Gerlich1,2,10 When vertebrate cells exit mitosis various cellular structures can contribute to Cdk1 substrate dephosphorylation during vertebrate are re-organized to build functional interphase cells1. This mitotic exit, whereas Ca2+-triggered mitotic exit in cytostatic-factor- depends on Cdk1 (cyclin dependent kinase 1) inactivation arrested egg extracts depends on calcineurin12,13. Early genetic studies in and subsequent dephosphorylation of its substrates2–4. Drosophila melanogaster 14,15 and Aspergillus nidulans16 reported defects Members of the protein phosphatase 1 and 2A (PP1 and in late mitosis of PP1 and PP2A mutants. However, the assays used in PP2A) families can dephosphorylate Cdk1 substrates in these studies were not specific for mitotic exit because they scored pro- biochemical extracts during mitotic exit5,6, but how this relates metaphase arrest or anaphase chromosome bridges, which can result to postmitotic reassembly of interphase structures in intact from defects in early mitosis. cells is not known. Here, we use a live-cell imaging assay and Intracellular targeting of Ser/Thr phosphatase complexes to specific RNAi knockdown to screen a genome-wide library of protein substrates is mediated by a diverse range of regulatory and targeting phosphatases for mitotic exit functions in human cells. We subunits that associate with a small group of catalytic subunits3,4,17.
    [Show full text]
  • Prediction of Response to Anti-Cancer Drugs Becomes Robust Via Network
    www.nature.com/scientificreports OPEN Prediction of response to anti- cancer drugs becomes robust via network integration of molecular Received: 24 September 2018 Accepted: 11 January 2019 data Published: xx xx xxxx Marcela Franco1, Ashwini Jeggari2, Sylvain Peuget1, Franziska Böttger1,3, Galina Selivanova1 & Andrey Alexeyenko 1,4 Despite the widening range of high-throughput platforms and exponential growth of generated data volume, the validation of biomarkers discovered from large-scale data remains a challenging feld. In order to tackle cancer heterogeneity and comply with the data dimensionality, a number of network and pathway approaches were invented but rarely systematically applied to this task. We propose a new method, called NEAmarker, for fnding sensitive and robust biomarkers at the pathway level. scores from network enrichment analysis transform the original space of altered genes into a lower- dimensional space of pathways. These dimensions are then correlated with phenotype variables. The method was frst tested using in vitro data from three anti-cancer drug screens and then on clinical data of The Cancer Genome Atlas. It proved superior to the single-gene and alternative enrichment analyses in terms of (1) universal applicability to diferent data types with a possibility of cross-platform integration, (2) consistency of the discovered correlates between independent drug screens, and (3) ability to explain diferential survival of treated patients. Our new screen of anti-cancer compounds validated the performance of multivariate models of drug sensitivity. The previously proposed methods of enrichment analysis could achieve comparable levels of performance in certain tests. However, only our method could discover predictors of both in vitro response and patient survival given administration of the same drug.
    [Show full text]
  • RESEARCH ARTICLE Salinity-Induced Regulation of the Myo-Inositol Biosynthesis Pathway in Tilapia Gill Epithelium
    4626 The Journal of Experimental Biology 216, 4626-4638 © 2013. Published by The Company of Biologists Ltd doi:10.1242/jeb.093823 RESEARCH ARTICLE Salinity-induced regulation of the myo-inositol biosynthesis pathway in tilapia gill epithelium Romina Sacchi, Johnathon Li, Fernando Villarreal, Alison M. Gardell and Dietmar Kültz* Physiological Genomics Group, Department of Animal Sciences, University of California, Davis, One Shields Avenue, Meyer Hall, Davis, CA 95616, USA *Author for correspondence ([email protected]) SUMMARY The myo-inositol biosynthesis (MIB) pathway converts glucose-6-phosphate to the compatible osmolyte myo-inositol that protects cells from osmotic stress. Using proteomics, the enzymes that constitute the MIB pathway, myo-inositol phosphate synthase (MIPS) and inositol monophosphatase 1 (IMPA1), are identified in tilapia (Oreochromis mossambicus) gill epithelium. Targeted, quantitative, label-free proteomics reveals that they are both upregulated during salinity stress. Upregulation is stronger when fish are exposed to severe (34 ppt acute and 90 ppt gradual) relative to moderate (70 ppt gradual) salinity stress. IMPA1 always responds more strongly than MIPS, suggesting that MIPS is more stable during salinity stress. MIPS is N-terminally acetylated and the corresponding peptide increases proportionally to MIPS protein, while non-acetylated N-terminal peptide is not detectable, indicating that MIPS acetylation is constitutive and may serve to stabilize the protein. Hyperosmotic induction of MIPS and IMPA1 is confirmed using western blot and real-time qPCR and is much higher at the mRNA than at the protein level. Two distinct MIPS mRNA variants are expressed in the gill, but one is more strongly regulated by salinity than the other.
    [Show full text]